Estimate Recalculated Sep 15, 2025 08:39PM EST
Merck & Co., Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Pandion Therapeutics, Inc., Harpoon Therapeutics, Inc., OPGEN INC, BeiGene, Ltd., Organon & Co., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..
Merck & Co., Inc.'s CIK is 0000310158
2021 was Merck & Co., Inc.'s most active year for disposing of shares, totalling 1 transactions. Merck & Co., Inc.'s most active month to dispose stocks was the month of May. In 2021 Merck & Co., Inc. cashed out on 253,516,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!